(Q51471819)

5 April 2018

title

L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. (English)

1 reference

5 April 2018

1 reference

7

Heiner Boeing

1 reference

5 April 2018

5

Matthias Möhlig

1 reference

5 April 2018

Joachim Spranger

6

Joachim Spranger

1 reference

5 April 2018

Jürgen Schrezenmeir

8

Jürgen Schrezenmeir

1 reference

5 April 2018

Eva Klein

1

Eva Fisher

1 reference

5 April 2018

Inka Lindner

4

Inka Lindner

1 reference

5 April 2018

Frank Döring

9

Frank Döring

1 reference

5 April 2018

Cornelia Weikert

2

Cornelia Weikert

1 reference

5 April 2018

author name string

Maja Klapper

3

1 reference

5 April 2018

publication date

7 May 2007

1 reference

5 April 2018

Molecular Genetics and Metabolism

published in

1 reference

5 April 2018

volume

91

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

278-284

1 reference

5 April 2018

Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Fatty acid-binding protein and its relation to fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Plasma concentrations of apolipoprotein B are modulated by a gene–diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

A case-cohort design for epidemiologic cohort studies and disease prevention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.03.002

10.1016/J.YMGME.2007.03.002

7 January 2021

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018